BioMed Research International

BioMed Research International / 2006 / Article
Special Issue

Neurodegenerative Diseases: Mechanisms and Therapies

View this Special Issue

Review Article | Open Access

Volume 2006 |Article ID 082323 | https://doi.org/10.1155/JBB/2006/82323

Akihiko Nunomura, Kazuhiro Honda, Atsushi Takeda, Keisuke Hirai, Xiongwei Zhu, Mark A. Smith, George Perry, "Oxidative Damage to RNA in Neurodegenerative Diseases", BioMed Research International, vol. 2006, Article ID 082323, 6 pages, 2006. https://doi.org/10.1155/JBB/2006/82323

Oxidative Damage to RNA in Neurodegenerative Diseases

Received05 Jan 2006
Accepted21 Apr 2006
Published25 May 2006

Abstract

Since 1999, oxidative damage to RNA molecules has been described in several neurological diseases including Alzheimer's disease, Parkinson's disease, Down syndrome, dementia with Lewy bodies, prion disease, subacute sclerosing panencephalitis, and xeroderma pigmentosum. An early involvement of RNA oxidation of vulnerable neuronal population in the neurodegenerative diseases has been demonstrated, which is strongly supported by a recent observation of increased RNA oxidation in brains of subjects with mild cognitive impairment. Until recently, little is known about consequences and cellular handling of the RNA damage. However, increasing body of evidence suggests detrimental effects of the RNA damage in protein synthesis and the existence of several coping mechanisms including direct repair and avoiding the incorporation of the damaged ribonucleotides into translational machinery. Further investigations toward understanding of the consequences and cellular handling mechanisms of the oxidative RNA damage may provide significant insights into the pathogenesis and therapeutic strategies of the neurodegenerative diseases.

References

  1. M A Smith, C A Rottkamp, A Nunomura, A K Raina, and G Perry, “Oxidative stress in Alzheimer's disease,” Biochimica et Biophysica Acta, vol. 1502, no. 1, pp. 139–144, 2000. View at: Google Scholar
  2. P Jenner, “Oxidative stress in Parkinson's disease,” Annals of Neurology, vol. 53, no. suppl 3, pp. S26–S38, 2003. View at: Google Scholar
  3. D Brégeon and A Sarasin, “Hypothetical role of RNA damage avoidance in preventing human disease,” Mutation Research, vol. 577, no. 1-2, pp. 293–302, 2005. View at: Google Scholar
  4. E S Fiala, C C Conaway, and J E Mathis, “Oxidative DNA and RNA damage in the livers of Sprague-Dawley rats treated with the hepatocarcinogen 2-nitropropane,” Cancer Research, vol. 49, no. 20, pp. 5518–5522, 1989. View at: Google Scholar
  5. W G Wamer and R R Wei, “In vitro photooxidation of nucleic acids by ultraviolet A radiation,” Photochemistry and Photobiology, vol. 65, no. 3, pp. 560–563, 1997. View at: Google Scholar
  6. T Hofer, C Badouard, E Bajak, J-L Ravanat, Å Mattsson, and I A Cotgreave, “Hydrogen peroxide causes greater oxidation in cellular RNA than in DNA,” Biological Chemistry, vol. 386, no. 4, pp. 333–337, 2005. View at: Google Scholar
  7. M Szymanski, M Z Barciszewska, V A Erdmann, and J Barciszewski, “A new frontier for molecular medicine: noncoding RNAs,” Biochimica et Biophysica Acta, vol. 1756, no. 1, pp. 65–75, 2005. View at: Google Scholar
  8. A Nunomura, G Perry, M A Pappolla et al., “RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease,” Journal of Neuroscience, vol. 19, no. 6, pp. 1959–1964, 1999. View at: Google Scholar
  9. J Zhang, G Perry, M A Smith et al., “Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons,” American Journal of Pathology, vol. 154, no. 5, pp. 1423–1429, 1999. View at: Google Scholar
  10. A Nunomura, G Perry, M A Pappolla et al., “Neuronal oxidative stress precedes amyloid-ß deposition in down syndrome,” Journal of Neuropathology and Experimental Neurology, vol. 59, no. 11, pp. 1011–1017, 2000. View at: Google Scholar
  11. A Nunomura, G Perry, G Aliev et al., “Oxidative damage is the earliest event in Alzheimer disease,” Journal of Neuropathology and Experimental Neurology, vol. 60, no. 8, pp. 759–767, 2001. View at: Google Scholar
  12. A Nunomura, S Chiba, K Kosaka et al., “Neuronal RNA oxidation is a prominent feature of dementia with Lewy bodies,” NeuroReport, vol. 13, no. 16, pp. 2035–2039, 2002. View at: Google Scholar
  13. A Nunomura, S Chiba, K Kosaka et al., “Erratum: neuronal RNA oxidation is a prominent feature of dementia with lewy bodies,” NeuroReport, vol. 14, no. 2, p. 293, 2003. View at: Google Scholar
  14. M Guentchev, S L Siedlak, C Jarius et al., “Oxidative damage to nucleic acids in human prion disease,” Neurobiology of Disease, vol. 9, no. 3, pp. 275–281, 2002. View at: Google Scholar
  15. M Hayashi, N Arai, J Satoh et al., “Neurodegenerative mechanisms in subacute sclerosing panencephalitis,” Journal of Child Neurology, vol. 17, no. 10, pp. 725–730, 2002. View at: Google Scholar
  16. T Abe, H Tohgi, C Isobe, T Murata, and C Sato, “Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease,” Journal of Neuroscience Research, vol. 70, no. 3, pp. 447–450, 2002. View at: Google Scholar
  17. A Kikuchi, A Takeda, H Onodera et al., “Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy,” Neurobiology of Disease, vol. 9, no. 2, pp. 244–248, 2002. View at: Google Scholar
  18. X Shan, H Tashiro, and C-L G Lin, “The identification and characterization of oxidized RNAs in Alzheimer's disease,” Journal of Neuroscience, vol. 23, no. 12, pp. 4913–4921, 2003. View at: Google Scholar
  19. X Shan and C-L G Lin, “Quantification of oxidized RNAs in Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 5, pp. 657–662, 2006. View at: Google Scholar
  20. T Abe, C Isobe, T Murata, C Sato, and H Tohgi, “Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease,” Neuroscience Letters, vol. 336, no. 2, pp. 105–108, 2003. View at: Google Scholar
  21. A Nunomura, S Chiba, C F Lippa et al., “Neuronal RNA oxidation is a prominent feature of familial Alzheimer's disease,” Neurobiology of Disease, vol. 17, no. 1, pp. 108–113, 2004. View at: Google Scholar
  22. K Honda, M A Smith, X Zhu et al., “Ribosomal RNA in Alzheimer disease is oxidized by bound redox-active iron,” Journal of Biological Chemistry, vol. 280, no. 22, pp. 20978–20986, 2005. View at: Google Scholar
  23. M Hayashi, S Araki, J Kohyama, K Shioda, and R Fukatsu, “Oxidative nucleotide damage and superoxide dismutase expression in the brains of xeroderma pigmentosum group A and Cockayne syndrome,” Brain and Development, vol. 27, no. 1, pp. 34–38, 2005. View at: Google Scholar
  24. R B Petersen, S L Siedlak, H-G Lee et al., “Redox metals and oxidative abnormalities in human prion diseases,” Acta Neuropathologica, vol. 110, no. 3, pp. 232–238, 2005. View at: Google Scholar
  25. Q Ding, W R Markesbery, Q Chen, F Li, and J N Keller, “Ribosome dysfunction is an early event in Alzheimer's disease,” Journal of Neuroscience, vol. 25, no. 40, pp. 9171–9175, 2005. View at: Google Scholar
  26. J Liu, E Head, A M Gharib et al., “Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: partial reversal by feeding acetyl-L-carnitine and/or R-a-lipoic acid,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 4, pp. 2356–2361, 2002. View at: Google Scholar
  27. B W Row, R Liu, W Xu, L Kheirandish, and D Gozal, “Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat,” American Journal of Respiratory and Critical Care Medicine, vol. 167, no. 11, pp. 1548–1553, 2003. View at: Google Scholar
  28. Q Ding, E Dimayuga, W R Markesbery, and J N Keller, “Proteasome inhibition increases DNA and RNA oxidation in astrocyte and neuron cultures,” Journal of Neurochemistry, vol. 91, no. 5, pp. 1211–1218, 2004. View at: Google Scholar
  29. E-M Park, M K Shigenaga, P Degan et al., “Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 8, pp. 3375–3379, 1992. View at: Google Scholar
  30. B Yin, R M Whyatt, F P Perera, M C Randall, T B Cooper, and R M Santella, “Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA,” Free Radical Biology and Medicine, vol. 18, no. 6, pp. 1023–1032, 1995. View at: Google Scholar
  31. J N Keller, F A Schmitt, S W Scheff et al., “Evidence of increased oxidative damage in subjects with mild cognitive impairment,” Neurology, vol. 64, no. 7, pp. 1152–1156, 2005. View at: Google Scholar
  32. D Praticò, C M Clark, F Liun, J Rokach, V Y Lee, and J Q Trojanowski, “Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease,” Archives of Neurology, vol. 59, no. 6, pp. 972–976, 2002. View at: Google Scholar
  33. L Migliore, I Fontana, F Trippi et al., “Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients,” Neurobiology of Aging, vol. 26, no. 5, pp. 567–573, 2005. View at: Google Scholar
  34. P Rinaldi, M C Polidori, A Metastasio et al., “Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease,” Neurobiology of Aging, vol. 24, no. 7, pp. 915–919, 2003. View at: Google Scholar
  35. I Guidi, D Galimberti, S Lonati et al., “Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease,” Neurobiology of Aging, vol. 27, no. 2, pp. 262–269, 2006. View at: Google Scholar
  36. A Nunomura, P I Moreira, X Zhu, A D Cash, M A Smith, and G Perry, “The role of oxidative insult and neuronal survival in Alzheimer and Parkinson diseases,” in Alzheimer's and Parkinson's Diseases: Insights, Progress and Perspectives, A Fisher, I Hanin, M Memo, and F Stocchi, Eds., Springer, New York, NY, In press. View at: Google Scholar
  37. A Nunomura, P I Moreira, X Zhu, M A Smith, and G Perry, “Involvement of oxidative stress in the early-stage of Alzheimer's disease: implications for therapeutics,” in Trends in Alzheimer's Disease Research, E M Welsh, Ed., Nova Science, Hauppauge, NY, In press. View at: Google Scholar
  38. K Hirai, G Aliev, A Nunomura et al., “Mitochondrial abnormalities in Alzheimer's disease,” Journal of Neuroscience, vol. 21, no. 9, pp. 3017–3023, 2001. View at: Google Scholar
  39. G Perry, A Nunomura, A D Cash et al., “Reactive oxygen: its sources and significance in Alzheimer disease,” Journal of Neural Transmission, Supplement, no. 62, pp. 69–75, 2002. View at: Google Scholar
  40. T Ishibashi, H Hayakawa, R Ito, M Miyazawa, Y Yamagata, and M Sekiguchi, “Mammalian enzymes for preventing transcriptional errors caused by oxidative damage,” Nucleic Acids Research, vol. 33, no. 12, pp. 3779–3784, 2005. View at: Google Scholar
  41. H Yanagawa, Y Ogawa, and M Ueno, “Redox ribonucleosides. Isolation and characterization of 5-hydroxyuridine, 8-hydroxyguanosine, and 8-hydroxyadenosine from Torula yeast RNA,” Journal of Biological Chemistry, vol. 267, no. 19, pp. 13320–13326, 1992. View at: Google Scholar
  42. A Bellacosa and E G Moss, “RNA repair: damage control,” Current Biology, vol. 13, no. 12, pp. R482–R484, 2003. View at: Google Scholar
  43. P A Aas, M Otterlei, P Ø Falnes et al., “Human and bacterial oxidative demethylases repair alkylation damage in both RNA and DNA,” Nature, vol. 421, no. 6925, pp. 859–863, 2003. View at: Google Scholar
  44. Y Nakabeppu, D Tsuchimoto, A Ichinoe et al., “Biological significance of the defense mechanisms against oxidative damage in nucleic acids caused by reactive oxygen species: from mitochondria to nuclei,” Annals of the New York Academy of Sciences, vol. 1011, pp. 101–111, 2004. View at: Google Scholar
  45. H Hayakawa, M Kuwano, and M Sekiguchi, “Specific binding of 8-oxoguanine-containing RNA to polynucleotide phosphorylase protein,” Biochemistry, vol. 40, no. 33, pp. 9977–9982, 2001. View at: Google Scholar
  46. H Hayakawa, T Uchiumi, T Fukuda et al., “Binding capacity of human YB-1 protein for RNA containing 8-oxoguanine,” Biochemistry, vol. 41, no. 42, pp. 12739–12744, 2002. View at: Google Scholar

Copyright © 2006 Akihiko Nunomura et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views193
Downloads663
Citations

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.